CN105213718A - For the Chinese medicine composition of malignant arrhythmia - Google Patents
For the Chinese medicine composition of malignant arrhythmia Download PDFInfo
- Publication number
- CN105213718A CN105213718A CN201510686107.0A CN201510686107A CN105213718A CN 105213718 A CN105213718 A CN 105213718A CN 201510686107 A CN201510686107 A CN 201510686107A CN 105213718 A CN105213718 A CN 105213718A
- Authority
- CN
- China
- Prior art keywords
- herba
- malignant arrhythmia
- chinese medicine
- medicine composition
- arrhythmia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of pharmaceutical formulation field, specifically a kind of Chinese medicine composition for malignant arrhythmia, it is characterized in that being made up of the crude drug of following weight portion: Radix Cochleariae officinalis grass 5 ~ 9, Pueraria lobota Bud 4 ~ 7, Folium Et Cacumen Murrayae 4 ~ 8, Herba Pyrolae 4 ~ 7, hyoscyami 4 ~ 8, Herba Clinopodii 5 ~ 8, Herba Euphorbiae Humifusae 6 ~ 9, Herba cypripedii japonici 6 ~ 9, Herba Typhae 7 ~ 9, Flos Magnoliae Officinalis 6 ~ 9, Caulis Spatholobi 2 ~ 5, Rhizoma Dioscoreae Septemlobae 6 ~ 9, Fructus Citri 2 ~ 5, Cordyceps militaris (L.) Link. 4 ~ 6, Herb Gynostemmae Pentaphylli 2 ~ 4, Herba Apocyni veneti 4 ~ 6, Herba Saxifragae 2 ~ 4, Fructus Phyllanthi 7 ~ 9, by medicinal for above-mentioned raw materials water soaking, to remove slag after decocting to obtain filtrate.The present invention treats the advantages such as coronary heart disease malignant arrhythmia is evident in efficacy, with low cost, without any side effects.
Description
Technical field
The present invention relates to a kind of Chinese patent medicine preparation, specifically a kind of Chinese medicine composition for malignant arrhythmia.
Background technology
As everyone knows, malignant arrhythmia mainly refers to quiver in the room speed of hemodynamic instability and room, and being the major reason of dying suddenly, is also the lethal one of the main reasons of coronary heart disease and arrhythmia patient.Most of malignant arrhythmia is with organic heart disease (as coronary heart disease, cardiomyopathy, heart failure etc.).Multiple clinical trial confirms that amiodarone can control the outbreak of malignant arrhythmia effectively in recent years, improves the effect of electrical conversion, reduces arrhythmia and general mortality rate.QT dispersion (QTd) significant prolongation in coronary heart disease malignant arrhythmia patient, and closely related with malignant arrhythmia.Amiodarone is the common drug for the treatment of Identifying Patients of Ventricular Arrhythmias With Coronary Artery Disease, and in the short time, the heavy dose of amiodarone of quiet note often proves effective, but long-term treatment, then there is larger side effect
Summary of the invention
Object of the present invention is exactly to overcome above-mentioned existing technical deficiency, provides a kind of evident in efficacy, with low cost, Chinese medicine composition for malignant arrhythmia of having no side effect.
The technical scheme that the present invention solves the problems of the technologies described above employing is: a kind of Chinese medicine composition for malignant arrhythmia, it is characterized in that being made up of the crude drug of following weight portion: Radix Cochleariae officinalis grass 5 ~ 9, Pueraria lobota Bud 4 ~ 7, Folium Et Cacumen Murrayae 4 ~ 8, Herba Pyrolae 4 ~ 7, hyoscyami 4 ~ 8, Herba Clinopodii 5 ~ 8, Herba Euphorbiae Humifusae 6 ~ 9, Herba cypripedii japonici 6 ~ 9, Herba Typhae 7 ~ 9, Flos Magnoliae Officinalis 6 ~ 9, Caulis Spatholobi 2 ~ 5, Rhizoma Dioscoreae Septemlobae 6 ~ 9, Fructus Citri 2 ~ 5, Cordyceps militaris (L.) Link. 4 ~ 6, Herb Gynostemmae Pentaphylli 2 ~ 4, Herba Apocyni veneti 4 ~ 6, Herba Saxifragae 2 ~ 4, Fructus Phyllanthi 7 ~ 9, by medicinal for above-mentioned raw materials water soaking, to remove slag after decocting to obtain filtrate.
The invention has the beneficial effects as follows, the advantages such as treatment coronary heart disease malignant arrhythmia is evident in efficacy, with low cost, without any side effects.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described:
Embodiment 1:
Radix Cochleariae officinalis grass, Pueraria lobota Bud, Folium Et Cacumen Murrayae, Herba Pyrolae, hyoscyami, Herba Clinopodii, Herba Euphorbiae Humifusae, Herba cypripedii japonici, Herba Typhae, Flos Magnoliae Officinalis, Caulis Spatholobi, Rhizoma Dioscoreae Septemlobae, Fructus Citri, Cordyceps militaris (L.) Link., Herb Gynostemmae Pentaphylli, Herba Apocyni veneti, Herba Saxifragae, Fructus Phyllanthi is adopted to be that raw material is prepared from.The every pair of its component (weight portion) is Radix Cochleariae officinalis grass 7, Pueraria lobota Bud 6, Folium Et Cacumen Murrayae 6, Herba Pyrolae 5, hyoscyami 6, Herba Clinopodii 6, Herba Euphorbiae Humifusae 7, Herba cypripedii japonici 7, Herba Typhae 8, Flos Magnoliae Officinalis 7, Caulis Spatholobi 4, Rhizoma Dioscoreae Septemlobae 8, Fructus Citri 3, Cordyceps militaris (L.) Link. 5, Herb Gynostemmae Pentaphylli 3, Herba Apocyni veneti 5, Herba Saxifragae 3, Fructus Phyllanthi 8.Get above-mentioned 18 taste raw materials, gross weight is 176 grams, add water 800 ~ 900 milliliters and at room temperature soak 5 ~ 6 hours, slow fire decocted to 60 ~ 80 minutes, filtrate about 150 milliliters of removing slag to obtain, and medicinal residues add water 200 ~ 300ml again, decoct 20 ~ 30 minutes, to remove slag to obtain filtrate 50 ~ 70 milliliters, altogether the medicine juice of about 200 ~ 220 milliliters, i.e. obtained decoction of the present invention.Load in sterile glass vials, seal bottle cap is for subsequent use, and every day 1 dose point 2 times is oral, sooner or later respectively once, and each (medicine) being taken before meal 100 ~ 110 milliliters.
Radix Cochleariae officinalis grass warming the meridian and promoting blood circulation of the present invention, promoting blood circulation and stopping pain.Main coronary heart disease, angina pectoris, thromboangiitis obliterans; Pueraria lobota Bud tonifying five ZANG-organs, reuniting the fractured tendons and bones, QI invigorating, quenches the thirst; Folium Et Cacumen Murrayae promoting flow of QI and blood, eliminating stasis to stop pain, removing toxic substances and promoting subsidence of swelling; Herba Pyrolae energy tonify deficiency, kidney tonifying, expelling wind and removing dampness, promoting blood flow to regulate menstruation, the kidney invigorating bone strengthening; Hyoscyami has the effect of determining epilepsy, pain relieving, be usually used in demented, the migratory arthralgia for the treatment of faint pain, breath with cough; Herba Clinopodii is used for metrorrhagia, hematuria, epistaxis, gingival hemorrhage, wound hemorrhage; Herba Euphorbiae Humifusae heat-clearing and toxic substances removing, dampness removing jaundice eliminating, promoting blood circulation and hemostasis; Herba cypripedii japonici has promoting blood flow to regulate menstruation, analgesia of dispeling the wind, the effects such as preventing the attack (or recurrence) of malaria; Herba Typhae hemostasis, pain relieving, granulation promoting; Flos Magnoliae Officinalis is regulated the flow of vital energy, removing dampness.For the vexed distension of breast gastral cavity painful abdominal mass, poor appetite; Caulis Spatholobi has relaxing muscles and tendons to promote blood circulation, and effect of nourishing blood for regulating menstruation, cures mainly rheumatic arthralgia, numb hand and foot, quadriplegia; Rhizoma Dioscoreae Septemlobae dampness removing goes turbid, wind expelling stagnation removing; Fructus Citri suppressing the hyperactive liver Shu Yu, reason lung qi, stimulate the menstrual flow diuretic, controls waist foot gas; Cordyceps militaris (L.) Link. can tonifying the lung cloudy, again can kidney-replenishing, cure mainly and suffer from a deficiency of the kidney, impotence and seminal emission, soreness of waist and knee joint; Herb Gynostemmae Pentaphylli replenishing QI to invigorate the spleen, preventing phlegm from forming and stopping coughing, heat-clearing and toxic substances removing; Herba Apocyni veneti is calm, anticonvulsant action, and has stronger diuresis, reduction blood fat, immunity moderation effect; Herba Saxifragae damp eliminating is subsided a swelling, cooling blood for hemostasis, heat-clearing and toxic substances removing; Fructus Phyllanthi helps digestion, diuretic, reduces phlegm, parasite killing.For vascular hypertension, stomachache, has loose bowels, scrofula.
The each raw material of the present invention also can the embodiment that mixes of ratio (weight portion) listed by according to the form below realize.Its processing technique is identical with embodiment 1.
The clinical trial carried out below in conjunction with my institute is done further the present invention, is described in detail:
1. data and method
1.1 physical data
All patients all meets the diagnostic criteria that WHO recommends, and is divided into two groups at random.Treatment group 50 example, male 27 example, women 23 example; Sick 31 examples of accompanied with hypertension, type 2 diabetes mellitus 17 example, 35 Cases of Hyperlipidemia.Matched group 50 example, male 24 example, women 26 example; Sick 29 examples of accompanied with hypertension, 2 type glycosuria 18 examples, hyperlipemia 32 example.Two groups of physical data no significant differences (P > 0.05).
1.2 Therapeutic Method
All take a routine treatment after patient people institute, intravenous amiodarone loading 3 ~ 5mg/kg, quiet note in 10min after dilution, vein maintenance dose is starting dose 1.0 ~ 1.5mg/min, according to state of an illness adjustment dosage; Auxiliary etiological treatment (polarized solution, aspirin, Statins, nitrate esters, ACEI and B receptor blocking agent), treatment group gives medicine of the present invention in the 1st day after amiodarone on treating, every day 1 dose point 2 times is oral, sooner or later each once, each (medicine) being taken before meal 100 ~ 110 milliliters.Matched group is treated routinely.Be 30 days the course for the treatment of.
1.3 observational technique
Often organize during medication and detect 12 lead electrocardiogram every day, except T, V wavelength-division circle is unclear or T ripple low flat lead outside, each measurement 3 Q-T that lead, interval, gets its meansigma methods, deducts the shortest QT interval be QTdo from the QT interval that difference is led the longest
1.4 statistical procedures
Application SPSS10.0 statistical software, measurement data represents with (X ± s), adopts X2 inspection and t inspection.
2. result
QT dispersion level close (P > 0.05) during two groups of patient admits
2.1 liang of group treatments period QT dispersion levels compare in table 1.
Table 1 treatments period QT dispersion level compares
After treatment the 1st day, two groups of QT dispersion levels all raised obviously, but two groups are compared difference there are no significant (P > 0.05); Later the 7th, 15,30 day two groups compare difference and all have significant difference (P < 0.01).
Treatment group on 7th compared with the 1st day, QT dispersion starts obviously to decline front and back significant difference (P < 0.05), until the 15th, the 30th compares, QT dispersion but still significantly lower than (P < 0.01) on the 1st.
Matched group on 7th compared with the 1st day, QT dispersion starts to decline, front and back difference has statistical significance (P < 0.05), but QT dispersion level level had declined not obvious (P > 0.05) compared with the 15th, the 30th on 1;
3. conclusion
Confirmed by above clinical trial, medicine of the present invention obviously can reduce the QT dispersion level of coronary heart disease malignant arrhythmia patient, determined curative effect, and therefore, medicine of the present invention effectively can treat coronary heart disease malignant arrhythmia.
Claims (1)
1. the Chinese medicine composition for malignant arrhythmia, it is characterized in that: be made up of the crude drug of following weight portion: Radix Cochleariae officinalis grass 5 ~ 9, Pueraria lobota Bud 4 ~ 7, Folium Et Cacumen Murrayae 4 ~ 8, Herba Pyrolae 4 ~ 7, hyoscyami 4 ~ 8, Herba Clinopodii 5 ~ 8, Herba Euphorbiae Humifusae 6 ~ 9, Herba cypripedii japonici 6 ~ 9, Herba Typhae 7 ~ 9, Flos Magnoliae Officinalis 6 ~ 9, Caulis Spatholobi 2 ~ 5, Rhizoma Dioscoreae Septemlobae 6 ~ 9, Fructus Citri 2 ~ 5, Cordyceps militaris (L.) Link. 4 ~ 6, Herb Gynostemmae Pentaphylli 2 ~ 4, Herba Apocyni veneti 4 ~ 6, Herba Saxifragae 2 ~ 4, Fructus Phyllanthi 7 ~ 9, by medicinal for above-mentioned raw materials water soaking, filtrate of removing slag after decocting to obtain.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510686107.0A CN105213718A (en) | 2015-10-15 | 2015-10-15 | For the Chinese medicine composition of malignant arrhythmia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510686107.0A CN105213718A (en) | 2015-10-15 | 2015-10-15 | For the Chinese medicine composition of malignant arrhythmia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105213718A true CN105213718A (en) | 2016-01-06 |
Family
ID=54983230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510686107.0A Pending CN105213718A (en) | 2015-10-15 | 2015-10-15 | For the Chinese medicine composition of malignant arrhythmia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105213718A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105726940A (en) * | 2016-04-05 | 2016-07-06 | 赵云 | Traditional Chinese medicine composition for treating coronary heart disease malignant arrhythmia |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104667176A (en) * | 2015-02-05 | 2015-06-03 | 孙春林 | Traditional Chinese medicine for treating malignant arrhythmia of coronary heart disease |
-
2015
- 2015-10-15 CN CN201510686107.0A patent/CN105213718A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104667176A (en) * | 2015-02-05 | 2015-06-03 | 孙春林 | Traditional Chinese medicine for treating malignant arrhythmia of coronary heart disease |
Non-Patent Citations (1)
Title |
---|
梁君昭 等: "扶正通络法治疗缓慢性心律失常", 《现代中医药》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105726940A (en) * | 2016-04-05 | 2016-07-06 | 赵云 | Traditional Chinese medicine composition for treating coronary heart disease malignant arrhythmia |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1240416C (en) | Medicine for curing hypertension and its preparation method | |
CN103705616A (en) | Formula of paste for removing slough and promoting growth of tissue regeneration | |
CN101612279B (en) | Chinese medicine preparation for promoting fracture healing | |
CN103041177A (en) | Chinese medicament for treating diabetic foot | |
CN104667176A (en) | Traditional Chinese medicine for treating malignant arrhythmia of coronary heart disease | |
CN102836338B (en) | Chinese medicament for treating cardia-cerebrovascular diseases | |
CN103989903A (en) | Traditional Chinese medicinal ointment for treating lumbar muscle strain and preparation method thereof | |
CN105213718A (en) | For the Chinese medicine composition of malignant arrhythmia | |
CN104474225B (en) | Medicine for treating viral myocarditis and preparation method | |
CN103393943A (en) | Traditional Chinese medicine composition for treating sequela of cerebral infarction | |
CN102743707B (en) | Pill for treating acute lumbar sprain | |
CN105381069A (en) | Traditional Chinese medicine oral liquid for treating hypertension | |
CN104784482A (en) | Traditional Chinese medicine for treating chronic pyogenic osteomyelitis | |
CN104189608B (en) | Traditional Chinese medicine preparation for recurrent oral ulcer and preparation method thereof | |
CN103877557B (en) | A kind of Chinese medicine ointment and preparation method for the treatment of tinea unguium | |
CN103341054B (en) | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
CN104840624A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
CN104096112A (en) | Traditional Chinese medicine composition for treating angina pectoris | |
CN1318049C (en) | Medicine for treating psoriasis | |
CN105012913A (en) | Drug for treating cold cough and preparation method of drug | |
CN104383057A (en) | Paste for mainly treating traumatic injury and preparation method of paste for mainly treating traumatic injury | |
CN104274668A (en) | Medicine for treating migraine | |
CN104435232B (en) | A kind of Chinese medicine composition for treating toothache | |
CN104623420B (en) | A kind of traditional Chinese herb medicine for treating flat wart | |
CN103070998B (en) | Externally-applied plaster for curing pain of rheumatic joints |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160106 |
|
WD01 | Invention patent application deemed withdrawn after publication |